Drug Shrinks Brain Tumors in Children with Tuberous Sclerosis, Study Suggests
A drug originally developed to prevent transplanted organ rejection has been shown to dramatically reduce a specific brain tumor in tuberous sclerosis patients, according to a new study led by Cincinnati Children’s.
Tuberous sclerosis is a rare genetic disease that causes tumors to grown on vital organs. The study is the latest to show the effectiveness of everolimus in slowing the overactive cell growth in TS patients.
“Every patient in this study experienced a decrease in size of their tumors, and no patient required surgery for their tumors after treatment with everolimus,” says Dr. David Franz, director of the Tuberous Sclerosis Clinic at Cincinnati Children’s and the study’s main author.